Ypsomed Holding Ownership

YPSN Stock  CHF 360.50  2.50  0.70%   
The market capitalization of Ypsomed Holding AG is ₣2.53 Billion. Ypsomed Holding AG maintains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 68.41 (%) of Ypsomed Holding AG outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with substantial debt, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.
Some institutional investors establish a significant position in stocks such as Ypsomed Holding in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Ypsomed Holding, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Ypsomed Holding AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Ypsomed Stock Ownership Analysis

About 68.0% of the company outstanding shares are owned by insiders. The book value of Ypsomed Holding was at this time reported as 37.29. The company last dividend was issued on the 4th of July 2022. Ypsomed Holding AG had 1629:1624 split on the 16th of June 2022. Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland. YPSOMED HLDG operates under Medical Devices classification in Switzerland and is traded on Switzerland Exchange. It employs 1522 people. For more information please call Simon Michel at 41 34 424 41 11 or visit https://www.ypsomed.com.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Ypsomed Stock Analysis

When running Ypsomed Holding's price analysis, check to measure Ypsomed Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ypsomed Holding is operating at the current time. Most of Ypsomed Holding's value examination focuses on studying past and present price action to predict the probability of Ypsomed Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ypsomed Holding's price. Additionally, you may evaluate how the addition of Ypsomed Holding to your portfolios can decrease your overall portfolio volatility.